Latest Asx News

Pivotal Metals has enhanced its Midrim Field exploration announcement by adding detailed assay data and launching an AI-driven program targeting high-grade copper-nickel-PGM deposits in Canada’s Belleterre-Angliers Greenstone Belt. The company aims to leverage historic drilling successes and modern geophysics to unlock new discoveries.

Australian Rare Earths Limited (ASX, AR3) reports strong progress in rare earth recovery and uranium exploration, alongside a successful capital raise and strategic U.S. government registrations.

Adherium Limited has successfully completed a $4.49 million entitlement offer, combining institutional and retail components, to fund expansion of its Hailie® digital respiratory monitoring platform.

Bowen Coking Coal Ltd has been hit with a $6.8 million statutory demand from contractor BUMA Australia, raising the spectre of insolvency if unresolved within 21 days. The dispute centers on claims and counterclaims involving liquidated damages.

Scalare Partners Holdings Limited has had its trading suspension lifted following its announcement of a capital raising to fund the acquisition of Tank Stream Labs.

Scalare Partners has raised $3 million through a share placement to fund its acquisition of Tank Stream Labs, alongside a $1.08 million Share Purchase Plan for existing shareholders. This capital raise aims to bolster Scalare’s position in the flexible workspace and tech investment sectors.

InVert Graphite’s initial trench assays at the Morogoro Project reveal wide zones of high-grade graphite, with grades reaching up to 29% Total Graphitic Carbon. The company is advancing to drilling to explore mineralisation at depth.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.

BPH Global Ltd reports a 17.7% revenue increase to A$177,316 in its second month of seaweed sales from Indonesia, signaling early commercial traction and sustainable growth potential.

Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.